NCT03223974View on ClinicalTrials.gov

Clinical Trial on Safety and Efficacy of Drug-coated Balloon in Treatment of Coronary Bifurcation Lesions

NACompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

November 16, 2017

Primary Completion Date

November 30, 2019

Study Completion Date

February 28, 2021

Conditions
Coronary Disease
Interventions
DEVICE

Paclitaxel DCB

Balloon/vessel diameter ratio 0.8-1.0, 8-10 ATM, lasting for \>30 seconds. If quantitative coronary angiography determines residual stenosis ≤ 30% , it is considered to be a successful operation.

DEVICE

DES

MB should be sufficiently predilated to facilitate the positioning of the stent and the stent residual stenosis should be ≤10% to be a successful operation.

Trial Locations (1)

100730

Beijing Hospital, Beijing

All Listed Sponsors
lead

Beijing Hospital

OTHER_GOV

NCT03223974 - Clinical Trial on Safety and Efficacy of Drug-coated Balloon in Treatment of Coronary Bifurcation Lesions | Biotech Hunter | Biotech Hunter